BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10361105)

  • 1. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.
    Hu XF; Slater A; Kantharidis P; Rischin D; Juneja S; Rossi R; Lee G; Parkin JD; Zalcberg JR
    Blood; 1999 Jun; 93(12):4086-95. PubMed ID: 10361105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
    Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the treatment of acute myeloid leukemia.
    Smeets M; de Witte T; van der Lely N; Raymakers R; Muus P
    Adv Exp Med Biol; 1999; 457():557-65. PubMed ID: 10500834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy.
    Broxterman HJ; Sonneveld P; van Putten WJ; Lankelma J; Eekman CA; Ossenkoppele GJ; Pinedo HM; Löwenberg B; Schuurhuis GJ
    Leukemia; 2000 Jun; 14(6):1018-24. PubMed ID: 10865967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
    Leith CP; Kopecky KJ; Godwin J; McConnell T; Slovak ML; Chen IM; Head DR; Appelbaum FR; Willman CL
    Blood; 1997 May; 89(9):3323-9. PubMed ID: 9129038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.
    Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Wessels H; de Witte T
    Blood; 1999 Oct; 94(7):2414-23. PubMed ID: 10498614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
    Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
    Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
    Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
    Pallis M; Russell N
    Blood; 2000 May; 95(9):2897-904. PubMed ID: 10779437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression.
    Müller MR; Lennartz K; Boogen C; Nowrousian MR; Rajewsky MF; Seeber S
    Ann Hematol; 1992 Nov; 65(5):206-12. PubMed ID: 1360820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
    Albertioni F; Gruber A; Areström I; Vitols S
    Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.
    Legrand O; Simonin G; Perrot JY; Zittoun R; Marie JP
    Adv Exp Med Biol; 1999; 457():161-75. PubMed ID: 10500791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients.
    Legrand O; Simonin G; Perrot JY; Zittoun R; Marie JP
    Blood; 1998 Jun; 91(12):4480-8. PubMed ID: 9616142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival.
    Guo Y; Köck K; Ritter CA; Chen ZS; Grube M; Jedlitschky G; Illmer T; Ayres M; Beck JF; Siegmund W; Ehninger G; Gandhi V; Kroemer HK; Kruh GD; Schaich M
    Clin Cancer Res; 2009 Mar; 15(5):1762-9. PubMed ID: 19240178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1/P-GP expression as a prognostic factor in acute leukemias.
    Marie JP; Legrand O
    Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
    Chaudhary PM; Roninson IB
    J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).
    Tang R; Faussat AM; Perrot JY; Marjanovic Z; Cohen S; Storme T; Morjani H; Legrand O; Marie JP
    BMC Cancer; 2008 Feb; 8():51. PubMed ID: 18271955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
    Lepelley P; Poulain S; Grardel N; Preudhomme C; Cosson A; Fenaux P
    Leuk Lymphoma; 1998 May; 29(5-6):547-51. PubMed ID: 9643568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
    Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
    Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.